A detailed history of Contravisory Investment Management, Inc. transactions in Incyte Corp stock. As of the latest transaction made, Contravisory Investment Management, Inc. holds 7,229 shares of INCY stock, worth $561,910. This represents 0.11% of its overall portfolio holdings.

Number of Shares
7,229
Holding current value
$561,910
% of portfolio
0.11%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

BUY
$57.33 - $68.61 $414,438 - $495,981
7,229 New
7,229 $477,000
Q2 2023

Jul 12, 2023

BUY
$60.95 - $75.51 $9,995 - $12,383
164 Added 2.29%
7,327 $456,000
Q1 2023

Apr 12, 2023

BUY
$70.23 - $86.01 $27,881 - $34,145
397 Added 5.87%
7,163 $517,000
Q4 2022

Jan 13, 2023

BUY
$67.18 - $84.11 $51,661 - $64,680
769 Added 12.82%
6,766 $0
Q2 2022

Jul 13, 2022

BUY
$66.18 - $83.18 $396,881 - $498,830
5,997 New
5,997 $456,000
Q4 2019

Jan 09, 2020

SELL
$73.04 - $95.72 $294,424 - $385,847
-4,031 Closed
0 $0
Q3 2019

Oct 07, 2019

BUY
$72.82 - $86.52 $509 - $605
7 Added 0.17%
4,031 $299,000
Q2 2019

Jul 09, 2019

BUY
$73.52 - $88.7 $295,844 - $356,928
4,024 New
4,024 $342,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $17.3B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Contravisory Investment Management, Inc. Portfolio

Follow Contravisory Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Contravisory Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Contravisory Investment Management, Inc. with notifications on news.